AstraZeneca PLC (AZN) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 3.36B | 2.43B | 5.13B | 3.39B | 3.71B | 2.91B | 3.38B | 3.08B | 2.49B | 2.38B | 3.11B | 1.72B | 3.13B | 2.4B | 2.93B | 1.25B | 3.23B | 1.42B | 1.72B | 892M |
| Operating CF Margin % | 21.97% | 15.67% | 33.8% | 23.42% | 27.33% | 19.52% | 24.94% | 23.84% | 19.61% | 19.79% | 27.1% | 15.05% | 28.8% | 21.4% | 26.68% | 11.59% | 28.38% | 11.81% | 17.42% | 10.85% |
| Operating CF Growth % | -9.53% | -16.41% | 51.76% | 9.76% | 49.36% | 22.14% | 8.64% | 79.57% | -20.65% | -0.75% | 6.28% | 37.66% | -3.06% | 69.11% | 70.45% | 39.91% | 67.11% | -21.13% | -5.65% | -14.23% |
| Net Income | 3.91B | 2.36B | 2.53B | 3.13B | 2.92B | 1.67B | 1.83B | 2.4B | 2.8B | 897M | 1.65B | 2.09B | 2.26B | 778M | 923M | 247M | 553M | -636M | -2B | 550M |
| Depreciation & Amortization | 1.37B | 1.53B | 1.55B | 1.39B | 1.28B | 714M | 1.82B | 1.28B | 1.25B | 874M | 1.28B | 1.28B | 1.5B | 1.48B | 1.33B | 1.36B | 1.31B | 2.19B | 2.79B | 753M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 579M | 0 | 0 | 0 | 619M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -579M | 0 | 0 | 0 | -619M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -921M | -228.99M | 217M | -785M | -61M | 877M | -303M | -462M | -1.11B | 459M | -717M | -657M | -873M | -159M | -394M | -943M | -434M | 1.31B | -274M | -58M |
| Working Capital Changes | -1B | -1.23B | 835M | -345M | -426M | -350M | 41M | -129M | -455M | 150M | 897M | -989M | 242M | 299M | 1.07B | 587M | 1.8B | -1.45B | 1.21B | -353M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.43B | 0 | 0 | 0 | -1.35B | 0 | 0 | 0 | -961M | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -669M | 0 | 0 | 0 | 3.94B | 0 | 0 | 0 | 1.58B | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.39B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -1.79B | -1.52B | -2B | -2.11B | -1.25B | -1.18B | -1.51B | -2.87B | -2.41B | -1.08B | -1.22B | -520M | -1.25B | -249M | -1.74B | -800M | -168M | -913M | -10.46B | -236M |
| Capital Expenditures | -547M | -1.3B | -686M | -659M | -429M | -708M | -417M | -382M | -1.6B | -946M | -879M | -483M | -1.47B | -554M | -1.11B | -543M | -363M | -718M | -660M | -288M |
| CapEx % of Revenue | 3.58% | 8.39% | 4.52% | 4.56% | 3.16% | 4.75% | 3.07% | 2.95% | 12.66% | 7.87% | 7.65% | 4.23% | 13.51% | 4.94% | 10.12% | 5.04% | 3.19% | 5.98% | 6.69% | 3.5% |
| Acquisitions | -281M | -258.71M | -328M | -267M | -362M | -274M | -281M | -2.3B | -940M | -296M | -273M | -184M | -426M | -189M | -342M | -288M | -242M | -218M | -9.63B | -138M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -871M | 40.59M | -987M | -1.11B | -462M | -167M | -834M | -308M | 123M | 83M | 94M | 92M | 631M | 304M | 33M | 64M | 388M | 32M | 18M | 190M |
| Cash from Financing | 267M | -3.36B | -2.08B | 518M | -2.71B | -671M | -4.13B | -1.22B | 2.03B | -291M | -2.73B | -1.52B | -2.03B | -358M | -1.43B | -1.29B | -3.74B | -1.05B | 142M | 7.29B |
| Debt Issued (Net) | 4.23B | -3.09B | -387.65M | 632M | 1.09B | -608M | -2.42B | -1.13B | 5.97B | -236M | -1.21B | -1.44B | 1.92B | -72M | 58M | -1.24B | -78M | -853M | 1.6B | -668M |
| Equity Issued (Net) | -602M | -175.32M | -7.85M | 1M | -478M | 23M | -77M | 5M | 6M | 21M | 4M | 4M | 4M | 18M | 3M | 3M | 5M | 19M | 1M | 4M |
| Dividends Paid | -3.29B | 12.37M | -1.6B | -10M | -3.35B | -3M | -1.58B | -17M | -3.03B | -2M | -1.41B | -22M | -3.05B | -102.72M | -1.39B | -89.15M | -2.97B | -14.52M | -1.39B | 16.28M |
| Share Repurchases | 0 | -198.78M | -12.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -72M | -100.7M | -80.76M | -105M | 23M | -83M | -59M | -76M | -915M | -74M | -111M | -62M | -907M | -201.28M | -98M | 29.15M | -696M | -202.48M | -68M | 7.96B |
| Net Change in Cash | 1.82B | -2.41B | 1.05B | 1.82B | -222M | 994M | -2.24B | -1.01B | 2.06B | 1.02B | -852M | -357M | -155M | 1.8B | -294M | -873M | -685M | -535M | -8.62B | 7.96B |
| Free Cash Flow | 1.82B | 1.38B | 4.45B | 1.46B | 3.28B | 1.95B | 2.02B | 2.42B | 881M | 1.43B | 2.23B | 1.24B | 1.66B | 1.84B | 1.82B | 705M | 2.87B | 700M | 1.06B | 604M |
| FCF Margin % | 11.91% | 8.88% | 29.28% | 10.12% | 24.17% | 13.11% | 14.93% | 18.68% | 6.95% | 11.93% | 19.45% | 10.82% | 15.29% | 16.45% | 16.56% | 6.55% | 25.19% | 5.83% | 10.73% | 7.35% |
| FCF Growth % | -44.55% | -29.48% | 119.65% | -39.47% | 272.76% | 36.12% | -9.4% | 95.71% | -47.02% | -22.23% | 22.87% | 75.18% | -42.04% | 163.43% | 71.77% | 16.72% | 95.84% | -44% | -5.19% | 858.73% |
| FCF per Share | 1.17 | 0.88 | 2.85 | 0.94 | 2.10 | 1.25 | 1.30 | 1.55 | 0.56 | 0.92 | 1.43 | 0.79 | 1.07 | 1.18 | 1.17 | 0.45 | 1.84 | 0.45 | 0.71 | 0.46 |
| FCF Conversion (FCF/Net Income) | 1.09x | 1.04x | 2.03x | 1.38x | 1.27x | 1.94x | 2.37x | 1.60x | 1.14x | 2.48x | 2.27x | 0.94x | 1.74x | 2.66x | 1.79x | 3.47x | 8.37x | -4.09x | -1.04x | 1.62x |
| Interest Paid | 0 | 0 | 446M | 0 | 422M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 136M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |